S. M. Abbas Rizvi

In vitro testing of the leukaemia monoclonal antibody WM-53 labeled with alpha and beta emitting radioisotopes.

G. Goozée, B. Allen, S. Rizvi, 2002, Leukemia research.

Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates

Yong Li, P. Russell, J. Beretov, 2009, Clinical Cancer Research.

Targeted Alpha Therapy Approach to the Management of Pancreatic Cancer

B. Allen, Ross C. Smith, S. M. Abbas Rizvi, 2011, Cancers.

Radioimmunoconjugates for targeted alpha therapy of malignant melanoma.

G. Goozée, B. Allen, S. M. Abbas Rizvi, 2000, Melanoma research.

Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.

Yong Li, B. Allen, P. Cozzi, 2004, Cancer letters.

Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.

Yong Li, Alan C Perkins, A. Perkins, 2004, International journal of radiation oncology, biology, physics.

Control of prostate cancer spheroid growth using 213Bi‐labeled multiple targeted α radioimmunoconjugates

Yong Li, M. Madigan, P. Russell, 2006, The Prostate.